Similar articles

• Effect of TSH on iodine metabolism and intermediary metabolism in tissue from patients with Graves' disease.

  Field JB, Larsen PR, Yamashita K, Chayoth R. Field JB, et al. J Clin Endocrinol Metab. 1974 Nov;39(5):942-9. doi: 10.1210/jcem-39-5-942. J Clin Endocrinol Metab. 1974. PMID: 4370784 No abstract available.
• In vitro demonstration of iodide-trapping defect but normal thyrotropin (TSH) responsiveness in benign and malignant "cold" thyroid nodules.

  Larsen PR, DeRubertis F, Yamashita K, Dekker A, Field JB. Larsen PR, et al. Trans Assoc Am Physicians. 1972;85:309-16. Trans Assoc Am Physicians. 1972. PMID: 4349622 No abstract available.
• Effect of iodine enrichment in vitro on the adenylate cyclase-adenosine 3',5' monophosphate system in thyroid glands from normal subjects and patients with Graves' disease.

  Uchimura H, Chiu SC, Kuzaya N, Ikeda H, Ito K, Nagataki S. Uchimura H, et al. J Clin Endocrinol Metab. 1980 Jun;50(6):1066-70. doi: 10.1210/jcem-50-6-1066. J Clin Endocrinol Metab. 1980. PMID: 6246144 No abstract available.
• [TSH and LATS].

  Ochi Y, Hachiya T, Shiomi K, Yoshimura M, Miyazaki T. Ochi Y, et al. Saishin Igaku. 1972 May;27(5):853-61. Saishin Igaku. 1972. PMID: 4339218 Review. Japanese. No abstract available.
• Characterization of the thyrotropin receptor and its involvement in Graves' disease.

  Kohn LD. Kohn LD. Horiz Biochem Biophys. 1977;3:123-63. Horiz Biochem Biophys. 1977. PMID: 69601 Review. No abstract available.